Valuation: RaySearch Laboratories AB

Market Cap 6.42B 677M 584M 548M 499M 939M 64.7B 952M 2.52B 32.41B 2.54B 2.49B 108B P/E 2026 *
23.9x
P/E 2027 * 19.2x
Enterprise Value 6.58B 693M 598M 561M 511M 961M 66.26B 975M 2.58B 33.19B 2.6B 2.55B 110B EV / Sales 2026 *
4.71x
EV / Sales 2027 * 3.94x
Free-Float
80.09%
Yield 2026 *
2.09%
Yield 2027 * 2.5%
1 day-3.01%
1 week+5.57%
Current month+4.97%
1 month+12.68%
3 months+7.35%
6 months+3.11%
Current year-16.61%
1 week 187.2
Extreme 187.2
199.8
1 month 164.55
Extreme 164.55
199.8
Current year 161
Extreme 161
237
1 year 161
Extreme 161
274.5
3 years 63.1
Extreme 63.1
369.5
5 years 40.8
Extreme 40.8
369.5
10 years 40.8
Extreme 40.8
369.5
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2000
Director of Finance/CFO 48 27/01/2025
Chief Tech/Sci/R&D Officer 53 28/08/2015
Director TitleAgeSince
Director/Board Member 57 01/01/2000
Chairman 81 18/11/2016
Chairman 87 30/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
-2.11%+5.57% - - 700M
-2.22%+3.41%-15.06%+24.16% 39.6B
-1.68%-0.12%-43.90%+150.98% 13.25B
-1.13%+4.71%-19.54%+64.80% 5.74B
-0.33%+45.52%+34.55% - 3.66B
+0.32%+9.34% - - 2.01B
-3.40%-2.12%+13.70%-43.21% 1.7B
+1.59%-3.77%-39.46% - 967M
+0.86%+1.73%+39.97%+132.02% 924M
-0.82%-0.55%-33.02%-46.28% 836M
Average -1.12%+7.03%-7.85%+47.08% 7.63B
Weighted average by Cap. -1.86%+6.78%-17.54%+53.81%

Financials

2026 *2027 *
Net sales 1.4B 147M 127M 119M 109M 204M 14.06B 207M 547M 7.05B 552M 540M 23.44B 1.63B 172M 148M 139M 127M 238M 16.43B 242M 639M 8.23B 645M 631M 27.38B
Net income 272M 28.65M 24.73M 23.2M 21.13M 39.74M 2.74B 40.29M 107M 1.37B 108M 105M 4.56B 338M 35.55M 30.69M 28.79M 26.22M 49.31M 3.4B 49.99M 132M 1.7B 133M 131M 5.66B
Net Debt 155M 16.33M 14.09M 13.22M 12.04M 22.64M 1.56B 22.96M 60.74M 782M 61.29M 59.97M 2.6B 7M 737K 636K 597K 544K 1.02M 70.49M 1.04M 2.74M 35.32M 2.77M 2.71M 117M
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
465
Date Price Change Volume
17/08/26 SEK 190.55 -2.11% 0
14/08/26 SEK 194.30 +2.18% 24,757
13/08/26 SEK 190.15 -0.34% 12,431
12/08/26 SEK 190.80 -0.93% 13,190
11/08/26 SEK 192.60 +1.20% 1,909
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
191.10SEK
Average target price
297.50SEK
Spread / Average Target
+55.68%

Quarterly revenue - Rate of surprise